Get the Latest Global and China Market Research Reports by AskLinker

In-depth analysis, competitive scenario, trends, forecasts and more

Ask Linker Reports
Growing Cases of Fungal Infections Drives the Global Antifungal Drugs Market
Published : 2016-12-20

The global antifungal drugs market is growing briskly owing to the upsurge in the frequency of fungal infections In addition to this, the substantial increasing awareness amongst the general populace and increase in disposable earnings will pep up the antifungal drugs market in the coming years.

The global antifungal drugs market was worth US$ 10.7 billion in 2015 and is anticipated to observe growth caused by the rising occurrence of fungal infections like pergillosis and candidiasis. These contagions may cause death in patients with lower immunity, such as in people aggrieved with AIDS and leukemia. The swelling pervasiveness of infectious maladies and hospital-acquired infections is projected to fuel the demand for therapeutics in the forthcoming years.

Fungal infection usually infects both superficial and systemic parts of the body - in the skin, mouth, eye, and vagina, causing ailments like fungal meningitis, athlete's foot, and ringworm. Antifungal products are used to treat these infections. An extensive array of fungicidal drugs, like sprays, creams, tablets, and injections, are obtainable and the growing acceptance of these products is projected to boost the demand over the next few years.

In addition, rising awareness relating to innumerable fungal infections is the significant causative factor for the growth of the antifungal drugs market. Organizations, such as FDA and the Centers for Disease Control and Prevention are aggressively involved in enlightening people as regards to the grim effect of infectious diseases. Also, budding R&D outlay together with growing backing from the public and private sector is estimated to offer this industry with profitable growth prospects. Rising approval of OTC antifungal drugs for skin infections is further underwriting the sector’s growth. Nevertheless, patent termination of branded drugs and presence of phoney drugs are elements estimated to inhibit the growth rate over the next few years.

North America trailed by Europe is dictating the global antifungal drugs market as high occurrence of fungal infections and advance of new antifungal biopharmaceuticals. In Asia Pacific, the antifungal drugs market is projected to bring noteworthy growth due to the rise in per capita earnings in this region which is anticipated to further boost the market demand. This development is also because the growing awareness for personal safety and healthcare. China is projected to record momentous market growth in antifungal drugs due to the increasing access of public with healthcare experts and developing economy. Also the antifungal drugs market is predictable to become exceedingly competitive due to entry of prospective participants in the market in the forthcoming years.

Read more on Medicine on:

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy